Singapore markets closed

CollPlant Biotechnologies Ltd. (CLGN)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
5.89+0.41 (+7.48%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-7,019
-7,019
-16,925
237
-5,774
Depreciation & amortisation
1,102
1,102
1,076
773
660
Stock-based compensation
1,937
1,937
2,174
1,597
1,674
Change in working capital
848
848
-544
216
-911
Accounts receivable
9
9
261
560
-751
Inventory
749
749
-312
181
-374
Accounts payable
-153
-153
99
236
-35
Other working capital
-3,717
-3,717
-15,014
912
-4,970
Other non-cash items
-28
-28
-87
-151
-40
Net cash provided by operating activities
-2,763
-2,763
-13,698
2,501
-4,451
Cash flows from investing activities
Investments in property, plant and equipment
-954
-954
-1,316
-1,589
-519
Purchases of investments
0
0
-20,000
-30,000
0
Sales/maturities of investments
0
0
50,238
0
0
Other investing activities
-270
-270
-
-
-
Net cash used for investing activities
-1,156
-1,156
28,922
-31,556
-519
Cash flows from financing activities
Debt repayment
-
-
0
0
-24
Common stock issued
0
0
0
32,743
4,400
Net cash used provided by (used for) financing activities
1,108
1,108
1,874
38,760
4,465
Net change in cash
-3,190
-3,190
16,490
9,848
-445
Cash at beginning of period
29,864
29,864
13,374
3,526
3,971
Cash at end of period
26,674
26,674
29,864
13,374
3,526
Free cash flow
Operating cash flow
-2,763
-2,763
-13,698
2,501
-4,451
Capital expenditure
-954
-954
-1,316
-1,589
-519
Free cash flow
-3,717
-3,717
-15,014
912
-4,970